Martin Sandgap
Commercial Director CEERJ at Sobi - Swedish Orphan Biovitrum AB (publ) | Zürich Metropolitan Area
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Commercial Director CEERJ at Sobi - Swedish Orphan Biovitrum AB (publ) in August 2024 to Present
Global Head of B2B at Acino in April 2023 to August 2024
Regional Business Director at Acino in August 2020 to April 2023
Global Head of Transformation at Acino in January 2019 to December 2020
Head of BEADS (Business Evaluation & Deal Structuring) at Acino in October 2014 to January 2019
Short Term Consultant at Cubist Pharmaceuticals in August 2014 to October 2014
Director Global Marketing - Commercial Assessment External Opportunities at Takeda Pharmaceuticals in August 2013 to December 2013
Director Global Marketing - Commercial Assessment External Opportunities at Takeda Pharmaceuticals in October 2012 to July 2013
Associate Director - Business Evaluation And Deal Structuring at Takeda Pharmaceuticals in October 2011 to September 2012
Associate Director - Business Evaluation and Deal Structuring at Nycomed in June 2010 to September 2011
Senior Manager Business Evaluation, Business Development at Nycomed in October 2008 to May 2010
International Product Manager at Nycomed in March 2005 to October 2008
Nordic Product Manager at Nordic Drugs in June 2001 to February 2005
Scandinavian Product Manager at UCB Pharma in December 1997 to May 2001
Sales Rep at UCB Pharma in March 1996 to November 1997
See more
See less
Lund University
See more
See less
Pharmaceutical Industry
Market Access
Sales Effectiveness
Clinical Development
Pharmaceutical Sales
Business Development
Segmentation
Product Launch
Global Marketing
Gastroenterology
Neurology
Market Analysis
Competitive Analysis
Oncology
Pharmaceutics
Product Management
Marketing Analytics
International Marketing
See more
See less
Discover more about Sobi - Swedish Orphan Biovitrum AB (publ)What is Martin Sandgap email address?
Email Martin Sandgap at [email protected]. This email is the most updated Martin Sandgap's email found in 2026.
How to contact Martin Sandgap?
To contact Martin Sandgap send an email to [email protected]. (updated on April 11, 2025)
What company does Martin Sandgap work for?
Martin Sandgap works for Sobi - Swedish Orphan Biovitrum AB (publ)
What is Martin Sandgap's role at Sobi - Swedish Orphan Biovitrum AB (publ)?
Martin Sandgap is Commercial Director CEERJ
What is Martin Sandgap's Phone Number?
Martin Sandgap's phone (**) *** *** 306
What industry does Martin Sandgap work in?
Martin Sandgap works in the Pharmaceuticals industry.
Martin Sandgap Email Addresses
Martin Sandgap Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Martin Sandgap
Senior Application and Sales Manager at Abstrax Tech, Inc
Leasing Consultant at Ray White Woollahra | Paddington
marketing director at Artistry
Quality Responsible and RA manager - Responsible Pharmacist Deputy at Sobi - Swedish Orphan Biovitrum AB (publ)
Accountant at Sobi - Swedish Orphan Biovitrum AB (publ)
Patient Access Senior Manager France (Market Access) at Sobi - Swedish Orphan Biovitrum AB (publ)
Clinical Project Manager at Sobi - Swedish Orphan Biovitrum AB (publ)
Senior Clinical Account Manager at Sobi - Swedish Orphan Biovitrum AB (publ)
Clinical Account Manager at Sobi - Swedish Orphan Biovitrum AB (publ)
Cellular Therapy Account Executive at Autolus Therapeutics
Key Account Manager at CTI BioPharma
Senior Clinical Account Manager at Sobi - Swedish Orphan Biovitrum AB (publ)
Owner at MAPS Capital, LLC
Show more
Show less